Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment; however, immune-related adverse events (irAEs) in the gastrointestinal (GI) system commonly occur. In this study, data were obtained from the US Food and Drug Administration adverse event reporting system between July 2014 and...
Saved in:
Main Authors: | Xiaoyin Bai (Author), Shiyu Jiang (Author), Yangzhong Zhou (Author), Hongnan Zhen (Author), Junyi Ji (Author), Yi Li (Author), Gechong Ruan (Author), Yang Yang (Author), Kaini Shen (Author), Luo Wang (Author), Guanqiao Li (Author), Hong Yang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune-related adverse events in small-cell lung cancer patients treated with immune checkpoint inhibitors: a comprehensive analysis from the FDA adverse event reporting system
by: Yifeng Bai, et al.
Published: (2024) -
Gastrointestinal disorders as immune-related adverse events
by: Daniele Balducci, et al.
Published: (2021) -
Delayed immune-related adverse events profile associated with immune checkpoint inhibitors: a real-world analysis
by: Yana Yang, et al.
Published: (2024) -
Adverse Events of Concurrent Immune Checkpoint Inhibitors and Antiangiogenic Agents: A Systematic Review
by: Ling Gao, et al.
Published: (2019) -
Adverse Events Following Immunization
by: L.I. Chernyshova
Published: (2014)